A parent applies a few drops of lavender on their child’s pillow to facilitate sleep and comes across an alarmist article mentioning endocrine disruptors. The logical reaction: stop everything. The reality is more nuanced, and understanding what lies behind this controversy requires going back to the studies themselves, their limitations, and the concrete situations where caution is truly warranted.
Gynecomastia in prepubescent boys: what the studies have actually tested
The controversy stems from clinical observations published as early as 2007: prepubescent boys exhibited abnormal breast development (gynecomastia) after regular exposure to products containing lavender or tea tree. Subsequent research expanded the findings to cases of early breast development in girls, with demonstrated estrogenic and anti-androgenic activity in vitro on certain constituents of these oils.
Related reading : Brad Pitt and the Vegan Diet: Truth, Motivations, and Benefits of His Dietary Choice
The problem lies in the nature of the implicated products. The often-cited American study (Ramsey et al., 2019) pointed to a lavender cologne that contained synthesized fragrances, not pure essential oil. We are therefore talking about complex mixtures where isolating the effect of a natural component like linalool becomes very uncertain.
In vitro tests, conducted on isolated cells exposed to often high concentrations, do not replicate the conditions of diluted topical application or occasional atmospheric diffusion. One can refer to the risks of lavender essential oil according to Conseils Beauté for an overview of current warnings, and the conclusion remains the same: direct evidence in humans, under conditions of common use, is still lacking.
Endocrine disruptor: what European regulation says about lavender
In 2022, the European Union introduced a specific hazard class “endocrine disruptor” in the CLP regulation with harmonized criteria. This advancement means that a component of essential oil (a terpene, for example) could theoretically be classified as ED if scientific evidence accumulates.
To date, neither linalool nor linalyl acetate, the two major molecules of true lavender essential oil (Lavandula angustifolia), appear on an official list of endocrine disruptors. In fact, no exhaustive list of EDs exists, creating a regulatory gray area for natural aromatic molecules.
Manufacturers of natural cosmetics, such as Weleda, claim to exclude substances recognized as EDs from their formulations while complying with regulation (EC) 1223/2009 on cosmetic products. The nuance is significant: “recognized as ED” is not the same as “suspected of hormonal activity in vitro”. Lavender-based products remain authorized for sale, including for baby ranges.
Lavender essential oil on the skin: concrete risk situations
The useful question is not “is lavender dangerous?” but rather “under what conditions does a risk exist?”. Feedback varies on this point among aromatherapy practitioners, but a few precautionary principles are widely agreed upon.
- Pure and repeated application on the skin of a child under three years old concentrates exposure to active compounds. Diluting the essential oil in a vegetable oil (to a few percent) significantly reduces the amount absorbed through the skin.
- Prolonged daily use over several months of the same product containing lavender (lotion, shower gel, scented laundry) creates chronic exposure that in vitro studies attempt to model. Alternating products limits this accumulation.
- Occasional atmospheric diffusion (twenty to thirty minutes) in a ventilated room represents the least concentrated mode of use. The documented hormonal risk mainly concerns direct and repeated topical application, not occasional inhalation.
- Pregnant women remain a case for heightened caution, not because a danger is proven, but because the fetal endocrine system is particularly sensitive to disruptions during the first trimester.
Organic labels and lavender essential oils: a false guarantee
An organic label certifies a mode of cultivation (absence of synthetic pesticides, adherence to agricultural specifications). It does not certify the absence of hormonal effects from a natural molecule. Specialized resources in environmental health remind us that organic labels do not guarantee the absence of endocrine disruptors in cosmetics. Linalool remains linalool, whether it comes from organic lavender from Haute-Provence or conventional cultivation.
Lavender and recognized properties: what remains valid despite the controversy
Reducing lavender to a potential endocrine disruptor would mean ignoring decades of documented use. The calming properties of Lavandula angustifolia on anxiety and sleep are supported by clinical studies. The mild sedative effect through inhalation is one of the best-documented in phytotherapy.
On the skin, true lavender essential oil has healing and anti-inflammatory properties used in hospital settings for superficial burns. These occasional and targeted uses do not pose the same problem as low-dose daily exposure over the long term.
The issue, for aromatic plants as for any active principle, remains the dose and frequency. Moderate and occasional use does not present the same risk profile as chronic exposure, especially in prepubescent children whose hormonal system is maturing. The controversy surrounding lavender mainly reminds us that no product, even natural, deserves systematic use without consideration of quantities and duration.